Amgen spinout Atara Biotherapeutics seeks $50 million IPO

Amgen Inc. spinout Atara Biotherapeutics Inc. already has its eye on a $50 million initial public offering...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.